Ed Cadman

2.0k total citations
58 papers, 1.6k citations indexed

About

Ed Cadman is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ed Cadman has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 25 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Ed Cadman's work include Biochemical and Molecular Research (20 papers), Colorectal Cancer Treatments and Studies (12 papers) and Lung Cancer Treatments and Mutations (7 papers). Ed Cadman is often cited by papers focused on Biochemical and Molecular Research (20 papers), Colorectal Cancer Treatments and Studies (12 papers) and Lung Cancer Treatments and Mutations (7 papers). Ed Cadman collaborates with scholars based in United States. Ed Cadman's co-authors include Robert Heimer, Joseph R. Bertino, Chris Benz, Lynn Davis, Robert L. Capizzi, Christopher C. Benz, Leonard R. Farber, R.D. Armstrong, Frank J. Rauscher and Leonard R. Prosnitz and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ed Cadman

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ed Cadman United States	23	696	555	360	358	206	58	1.6k
Holland Jf United States	19	557 0.8×	468 0.8×	211 0.6×	314 0.9×	198 1.0×	69	1.5k
John J. Costanzi United States	23	509 0.7×	371 0.7×	226 0.6×	280 0.8×	83 0.4×	56	1.5k
J F Holland United States	21	664 1.0×	421 0.8×	211 0.6×	243 0.7×	97 0.5×	49	1.3k
Robert W. Talley United States	23	1.1k 1.6×	456 0.8×	695 1.9×	722 2.0×	183 0.9×	53	2.4k
R Plagne France	17	560 0.8×	282 0.5×	186 0.5×	144 0.4×	76 0.4×	100	1.3k
Takao Ohnuma United States	22	462 0.7×	592 1.1×	121 0.3×	174 0.5×	352 1.7×	81	1.5k
J.H. Goldie Canada	20	480 0.7×	384 0.7×	108 0.3×	206 0.6×	165 0.8×	53	1.4k
Laster Wr United States	18	574 0.8×	433 0.8×	117 0.3×	242 0.7×	84 0.4×	28	1.2k
D Schlaifer France	22	906 1.3×	436 0.8×	796 2.2×	170 0.5×	71 0.3×	52	1.6k
Rose Ruth Ellison United States	22	450 0.6×	416 0.7×	204 0.6×	244 0.7×	554 2.7×	55	1.9k

Countries citing papers authored by Ed Cadman

Since Specialization

Citations

This map shows the geographic impact of Ed Cadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Cadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Cadman more than expected).

Fields of papers citing papers by Ed Cadman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Cadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Cadman. The network helps show where Ed Cadman may publish in the future.

Co-authorship network of co-authors of Ed Cadman

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Cadman. A scholar is included among the top collaborators of Ed Cadman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Cadman. Ed Cadman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rochlitz, Christoph, et al.. (1988). Cytotoxicity of ketoconazole in malignant cell lines. Cancer Chemotherapy and Pharmacology. 21(4). 319–22. 37 indexed citations

Takimoto, Chris H., Ed Cadman, & R.D. Armstrong. (1986). Precursor-dependent differences in the incorporation of fluorouracil in RNA.. Molecular Pharmacology. 29(6). 637–642. 11 indexed citations

Hait, W N, et al.. (1985). Inhibition of growth of leukemic cells by inhibitors of calmodulin: Phenothiazines and melittin. Cancer Chemotherapy and Pharmacology. 14(3). 202–5. 79 indexed citations

Cadman, Ed & C Benz. (1984). Cytotoxicity of several chemotherapeutic agents in a human pancreatic cancer cell line (Colo-357).. PubMed. 68(2). 429–30. 3 indexed citations

Armstrong, R.D. & Ed Cadman. (1983). 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow.. PubMed. 43(6). 2525–8. 41 indexed citations

Armstrong, R.D., et al.. (1983). Mechanism of cytotoxic activity of 5?-deoxy-5-fluorouridine. Cancer Chemotherapy and Pharmacology. 11(2). 102–5. 12 indexed citations

Cadman, Ed, Leonard R. Prosnitz, Leonard R. Farber, et al.. (1983). The effective use of combined modality therapy for the treatment of patients with Hodgkinʼs disease who relapsed following radiotherapy. American Journal of Clinical Oncology. 6(3). 313–318. 12 indexed citations

Grant, Steven, Kapil N. Bhalla, Frank J. Rauscher, & Ed Cadman. (1983). Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.. PubMed. 43(11). 5093–100. 7 indexed citations

Newcomer, Lee N., et al.. (1982). Bone involvement in Hodgkin's disease. Cancer. 49(2). 338–342. 41 indexed citations

10.

Benz, Chris, et al.. (1982). Phase I pilot study using 24 hour sequenced methotrexate and 5-fluorouracil. 1. 1 indexed citations

11.

Grant, Steven, Frank J. Rauscher, & Ed Cadman. (1982). Differential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors.. PubMed. 42(10). 4007–13. 10 indexed citations

12.

Cadman, Ed, Christopher C. Benz, Robert Heimer, & Joyce O’Shaughnessy. (1981). Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity. Biochemical Pharmacology. 30(17). 2469–2472. 23 indexed citations

13.

Grant, Steven, Frank J. Rauscher, Ann A. Jakubowski, & Ed Cadman. (1981). Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.. PubMed. 41(2). 410–8. 11 indexed citations

14.

Grant, Steven & Ed Cadman. (1980). Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.. PubMed. 40(11). 4000–6. 8 indexed citations

15.

Cadman, Ed, et al.. (1980). Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.. PubMed. 40(5). 1525–31. 51 indexed citations

16.

Cadman, Ed, Christopher C. Benz, & Robert Heimer. (1979). Enhanced 5-fluorouracil (5-fu) nucleotide formation following methotrexate (mtx) is the consequence of increased intracellular phosphoribosylpyrophosphate (prpp). Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 258. 2 indexed citations

17.

Cadman, Ed, et al.. (1978). Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells.. PubMed. 38(12). 4610–7. 26 indexed citations

18.

Cadman, Ed, et al.. (1977). Enhanced intracellular cytosine arabinoside uptake following mtx pretreatment. A biochemical study of human leukemia and experimental tumor cells. Abstr.. Trauma Surgery & Acute Care Open. 9(Suppl 1). 216–e001151. 1 indexed citations

19.

Cadman, Ed, et al.. (1977). A fluorometric assay for dihydrofolate reductase. Analytical Biochemistry. 83(1). 20–25. 6 indexed citations

20.

Cadman, Ed & Joseph R. Bertino. (1976). Chemotherapy of skeletal metastases. International Journal of Radiation Oncology*Biology*Physics. 1(11-12). 1211–1215. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact